Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy
- Author
- SUNAGA, Noriaki1 ; TOMIZAWA, Yoshio1 2 ; SAITO, Ryusei2 ; DOBASHI, Kunio6 ; MORI, Masatomo1 ; YANAGITANI, Noriko1 ; IIJIMA, Hironobu1 2 ; KAIRA, Kyoichi1 ; SHIMIZU, Kimihiro3 ; TANAKA, Shigebumi4 ; SUGA, Tatsuo5 ; HISADA, Takeshi1 ; ISHIZUKA, Tamotsu1
[1] Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
[2] Department of Respiratory Medicine, National Nishigunma Hospital, Japan
[3] Department of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine, Japan
[4] Department of General Surgical Science, Gunma University Graduate School of Medicine, Japan
[5] Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Japan
[6] Gunma University School of Health Sciences, Japan - Source
Lung cancer. 2007, Vol 56, Num 3, pp 383-389, 7 p ; ref : 39 ref
- CODEN
- LUCAE5
- ISSN
- 0169-5002
- Scientific domain
- Medical oncology; Pneumology
- Publisher
- Elsevier Science, Shannon
- Publication country
- Ireland
- Document type
- Article
- Language
- English
- Author keyword
- Epidermal growth factor receptor Gefitinib Mutation Non-small cell lung cancer
- Keyword (fr)
- Appareil respiratoire pathologie Cancérologie Carcinome non petite cellule bronchopulmonaire Carcinome non petite cellule Chimiothérapie Efficacité Essai clinique phase II Géfitinib Mutation Pneumologie Prospective Récepteur facteur croissance épiderme Stade avancé Traitement Bronche pathologie Poumon pathologie Tumeur maligne
- Keyword (en)
- Respiratory disease Cancerology non-small cell lung carcinoma Non small cell carcinoma Chemotherapy Efficiency Phase II trial Gefitinib Mutation Pneumology Prospective Epidermal growth factor receptor Advanced stage Treatment Bronchus disease Lung disease Malignant tumor
- Keyword (es)
- Aparato respiratorio patología Cancerología Carcinoma no pequeňa célula bronchopulmonar Carcinoma no pequeña célula Quimioterapia Eficacia Ensayo clínico fase II Gefitinib Mutación Neumología Prospectiva Receptor factor crecimiento epidermi Estadio avanzado Tratamiento Bronquio patología Pulmón patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum
- Discipline
- Pulmonology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18768508
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.lungcan.2007.01.025 
https://dx.doi.org/10.1016/j.lungcan.2007.01.025
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2007.01.025\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:175:\"Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III\/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy\";s:9:\"\u0000*\u0000jtitle\";s:11:\"Lung cancer\";s:9:\"\u0000*\u0000stitle\";s:11:\"Lung cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"56\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"383\";s:8:\"\u0000*\u0000epage\";s:3:\"389\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0169-5002\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"SUNAGA\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Noriaki\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"TOMIZAWA, Yoshio\";i:1;s:13:\"SAITO, Ryusei\";i:2;s:14:\"DOBASHI, Kunio\";i:3;s:14:\"MORI, Masatomo\";i:4;s:18:\"YANAGITANI, Noriko\";i:5;s:16:\"IIJIMA, Hironobu\";i:6;s:14:\"KAIRA, Kyoichi\";i:7;s:17:\"SHIMIZU, Kimihiro\";i:8;s:17:\"TANAKA, Shigebumi\";i:9;s:12:\"SUGA, Tatsuo\";i:10;s:15:\"HISADA, Takeshi\";i:11;s:17:\"ISHIZUKA, Tamotsu\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LUCAE5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:175:\"Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III\/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy\";s:8:\"\u0000*\u0000place\";s:7:\"Shannon\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2007.01.025\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:175:\"Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III\/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy\";s:9:\"\u0000*\u0000jtitle\";s:11:\"Lung cancer\";s:9:\"\u0000*\u0000stitle\";s:11:\"Lung cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"56\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"383\";s:8:\"\u0000*\u0000epage\";s:3:\"389\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0169-5002\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"SUNAGA\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Noriaki\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"TOMIZAWA, Yoshio\";i:1;s:13:\"SAITO, Ryusei\";i:2;s:14:\"DOBASHI, Kunio\";i:3;s:14:\"MORI, Masatomo\";i:4;s:18:\"YANAGITANI, Noriko\";i:5;s:16:\"IIJIMA, Hironobu\";i:6;s:14:\"KAIRA, Kyoichi\";i:7;s:17:\"SHIMIZU, Kimihiro\";i:8;s:17:\"TANAKA, Shigebumi\";i:9;s:12:\"SUGA, Tatsuo\";i:10;s:15:\"HISADA, Takeshi\";i:11;s:17:\"ISHIZUKA, Tamotsu\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LUCAE5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:175:\"Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III\/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy\";s:8:\"\u0000*\u0000place\";s:7:\"Shannon\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2007.01.025\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2007.01.025\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:175:\"Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III\/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy\";s:9:\"\u0000*\u0000jtitle\";s:11:\"Lung cancer\";s:9:\"\u0000*\u0000stitle\";s:11:\"Lung cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"56\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"383\";s:8:\"\u0000*\u0000epage\";s:3:\"389\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0169-5002\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"SUNAGA\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Noriaki\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"TOMIZAWA, Yoshio\";i:1;s:13:\"SAITO, Ryusei\";i:2;s:14:\"DOBASHI, Kunio\";i:3;s:14:\"MORI, Masatomo\";i:4;s:18:\"YANAGITANI, Noriko\";i:5;s:16:\"IIJIMA, Hironobu\";i:6;s:14:\"KAIRA, Kyoichi\";i:7;s:17:\"SHIMIZU, Kimihiro\";i:8;s:17:\"TANAKA, Shigebumi\";i:9;s:12:\"SUGA, Tatsuo\";i:10;s:15:\"HISADA, Takeshi\";i:11;s:17:\"ISHIZUKA, Tamotsu\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LUCAE5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:175:\"Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III\/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy\";s:8:\"\u0000*\u0000place\";s:7:\"Shannon\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2007.01.025\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:175:\"Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III\/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy\";s:9:\"\u0000*\u0000jtitle\";s:11:\"Lung cancer\";s:9:\"\u0000*\u0000stitle\";s:11:\"Lung cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"56\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"383\";s:8:\"\u0000*\u0000epage\";s:3:\"389\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0169-5002\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"SUNAGA\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Noriaki\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"TOMIZAWA, Yoshio\";i:1;s:13:\"SAITO, Ryusei\";i:2;s:14:\"DOBASHI, Kunio\";i:3;s:14:\"MORI, Masatomo\";i:4;s:18:\"YANAGITANI, Noriko\";i:5;s:16:\"IIJIMA, Hironobu\";i:6;s:14:\"KAIRA, Kyoichi\";i:7;s:17:\"SHIMIZU, Kimihiro\";i:8;s:17:\"TANAKA, Shigebumi\";i:9;s:12:\"SUGA, Tatsuo\";i:10;s:15:\"HISADA, Takeshi\";i:11;s:17:\"ISHIZUKA, Tamotsu\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LUCAE5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:175:\"Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III\/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy\";s:8:\"\u0000*\u0000place\";s:7:\"Shannon\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.lungcan.2007.01.025\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:175:\"Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III\/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy\";s:9:\"\u0000*\u0000jtitle\";s:11:\"Lung cancer\";s:9:\"\u0000*\u0000stitle\";s:11:\"Lung cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"56\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"383\";s:8:\"\u0000*\u0000epage\";s:3:\"389\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0169-5002\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"SUNAGA\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Noriaki\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"TOMIZAWA, Yoshio\";i:1;s:13:\"SAITO, Ryusei\";i:2;s:14:\"DOBASHI, Kunio\";i:3;s:14:\"MORI, Masatomo\";i:4;s:18:\"YANAGITANI, Noriko\";i:5;s:16:\"IIJIMA, Hironobu\";i:6;s:14:\"KAIRA, Kyoichi\";i:7;s:17:\"SHIMIZU, Kimihiro\";i:8;s:17:\"TANAKA, Shigebumi\";i:9;s:12:\"SUGA, Tatsuo\";i:10;s:15:\"HISADA, Takeshi\";i:11;s:17:\"ISHIZUKA, Tamotsu\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LUCAE5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:175:\"Phase ii prospective study of the efficacy of gefitinib for the treatment of stage III\/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy\";s:8:\"\u0000*\u0000place\";s:7:\"Shannon\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
